STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

RxSight (Nasdaq: RXST) will host multiple Live Learning Sessions at AAO 2025 in Orlando, Oct 18–20, at Booth #2931. Sessions feature surgeons sharing real-world experience with the Light Adjustable Lens, focusing on clinical advantages and economic implications of adjustability.

Scheduled talks run Oct 18 (10:00 AM–3:00 PM) and Oct 19 (10:00 AM–1:00 PM) and cover topics such as ROI, career impact, premium lens adoption, patient-centered outcomes, and practical counseling for Light Adjustable Lens patients.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 29 Alerts

-2.83% News Effect
+5.9% Peak in 2 hr 28 min
-$10M Valuation Impact
$359M Market Cap
0.8x Rel. Volume

On the day this news was published, RXST declined 2.83%, reflecting a moderate negative market reaction. Argus tracked a peak move of +5.9% during that session. Our momentum scanner triggered 29 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $10M from the company's valuation, bringing the market cap to $359M at that time.

Data tracked by StockTitan Argus on the day of publication.

ALISO VIEJO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced it will be featured in multiple Live Learning Sessions at Booth #2931 during the American Academy of Ophthalmology Annual Meeting (AAO 2025), taking place October 18–20 at the Orange County Convention Center in Orlando, Fla.

This year’s Live Learning Sessions showcase real-world insights from leading surgeons who have incorporated the Light Adjustable Lens into their practices, highlighting the clinical advantages and the economic impact of adjustability.

LIVE LEARNING SESSIONS – RxSight Booth #2931

Saturday, October 18

10:00 AMROI You Can See with the Light Adjustable Lens
Taylor Strange, DO and Kasey Gantz – Alliance Vision Institute, Texas

11:00 AMJump Starting My Career with the Light Adjustable Lens
Brian Szabo, DO – Newsom Eye, Florida

12:00 PMLocking in Clinical Confidence with the Light Adjustable Lens
Tanner Ferguson, MD – Vance Thompson Vision, South Dakota

1:00 PMAccelerating Premium Lens Adoption with the Light Adjustable Lens
Matt Kaufman, MD – Eye Health Northwest, Oregon

2:00 PMWho Really Benefits from the Light Adjustable Lens?
Eva Kim, MD – ICON Eyecare, Colorado

3:00 PMDiscovering Versatility with the Light Adjustable Lens
Quentin Allen, MD – Florida Vision Institute, Florida

Sunday, October 19

10:00 AMStarting Strong with the Light Adjustable Lens
Alison Early, MD – Signature Cataract & Laser Consultants, Ohio

11:00 AMSeeing Outcomes in a New Light with the Light Adjustable Lens
John Doane, MD – Discover Vision Centers, Kansas

12:00 PMThe Right Words for the Right Light Adjustable Lens Experience
Thomas Meirick, MD – Wolfe Eye Clinic, Iowa

1:00 PMThe Power of Adjustability: Patient-Centered Outcomes with the Light Adjustable Lens
John Josephson, MD – Eye Specialists and Surgeons of Northern Virginia, Virginia

About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com


FAQ

When and where will RxSight present Live Learning Sessions for RXST at AAO 2025?

RxSight will present Live Learning Sessions at AAO 2025 in Orlando, Oct 18–20, at Booth #2931.

What topics will RXST sessions cover about the Light Adjustable Lens at AAO 2025?

Sessions cover clinical advantages, economic impact, ROI, premium lens adoption, patient outcomes, and counseling for the Light Adjustable Lens.

Which surgeons are speaking for RxSight (RXST) on Oct 18 at AAO 2025?

Speakers on Oct 18 include Taylor Strange, Kasey Gantz, Brian Szabo, Tanner Ferguson, Matt Kaufman, Eva Kim, and Quentin Allen.

What is the schedule for RxSight (RXST) Live Learning Sessions on Oct 19 at AAO 2025?

Oct 19 sessions run 10:00 AM–1:00 PM with presentations by Alison Early, John Doane, Thomas Meirick, and John Josephson.

How can ophthalmologists learn practical outcomes for the Light Adjustable Lens at RXST's AAO sessions?

Attendees can hear real-world case experience and surgeon perspectives on outcomes and practice adoption during the live sessions at Booth #2931.

Will RxSight (RXST) discuss the economic impact of the Light Adjustable Lens at AAO 2025?

Yes; sessions explicitly highlight the economic impact and ROI of incorporating the Light Adjustable Lens into practice.
Rxsight, Inc.

NASDAQ:RXST

RXST Rankings

RXST Latest News

RXST Latest SEC Filings

RXST Stock Data

516.42M
38.59M
5.56%
96.93%
13.31%
Medical Devices
Ophthalmic Goods
Link
United States
ALISO VIEJO